Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rxo (RXO) Shares Outstanding (Diluted Average) (2021 - 2025)

Rxo's Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $168.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 26.27% year-over-year to $168.5 million; the TTM value through Dec 2025 reached $168.5 million, up 26.27%, while the annual FY2025 figure was $168.5 million, 26.27% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $168.5 million in Q4 2025 per RXO's latest filing, roughly flat from $168.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $168.5 million in Q2 2025 to a low of $115.0 million in Q3 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $129.5 million, with a median of $118.4 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 1.8% in 2024, then surged 43.55% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $115.2 million in 2021, then increased by 0.55% to $115.8 million in 2022, then grew by 3.17% to $119.5 million in 2023, then increased by 11.68% to $133.4 million in 2024, then grew by 26.27% to $168.5 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Shares Outstanding (Diluted Average) are $168.5 million (Q4 2025), $168.4 million (Q3 2025), and $168.5 million (Q2 2025).